China's healthcare-focused LYFE Capital leads $92m funding in biotech firm ABclonal
streetAsias premium subscription service Unlock your competitive advantage in a rapidly evolving landscape. Our packages come with exclusive access to archive content, data, discount on summit tickets & more. Be a part of our growing community now. SUBSCRIBE NOW Singapore Reporter/s In Singapore, we are lookin...
United States Oriza Fofs Xiamencd Inc Abclonal Technology Capital China China Based Sigma Square Capital
Source: dealstreetasia.com